Literature DB >> 8773213

Clinical symptoms and regional cerebral blood flow in schizophrenia.

S Yuasa1, M Kurachi, M Suzuki, Y Kadono, M Matsui, O Saitoh, H Seto.   

Abstract

This study examined the relationship between clinical symptoms and regional cerebral blood flow (rCBF) in schizophrenic patients using single photon emission computed tomography (SPECT). The subjects were 26 medicated schizophrenic patients diagnosed according to DSM-III-R criteria. Clinical symptoms were assessed using the Scale for the Assessment of Negative Symptoms (SANS), selected items for the Positive and Negative Syndrome Scale (PANSS), and the scale for Schneider's first rank symptoms. Resting rCBF was measured using N-isopropyl-p-[I-123] iodoamphetamine (I-123 IMP) SPECT, and relative rCBF distribution was evaluated in nine regions of interest in each hemisphere. Factor analysis of symptom ratings indicated four separate syndromes: psychomotor poverty, alienation (hallucination and disturbance of the self), delusion, and disorganization. Stepwise multiple regression analysis showed the psychomotor poverty syndrome to be correlated with decreased rCBF in bilateral superior frontal areas and increased rCBF in the left thalamus and right basal ganglia. The disorganization syndrome was correlated with increased rCBF in bilateral anterior cingulates and decreased rCBF in bilateral middle frontal areas. The alienation syndrome was shown related to increased rCBF in the right inferior frontal area and parietal area. Dysfunction in distinctive neural networks involving various prefrontal areas would thus appear to underlie these syndromes in schizophrenia.

Entities:  

Mesh:

Year:  1995        PMID: 8773213     DOI: 10.1007/bf02191809

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  27 in total

Review 1.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

Authors:  A A Grace
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

2.  Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.

Authors:  F M Benes; J McSparren; E D Bird; J P SanGiovanni; S L Vincent
Journal:  Arch Gen Psychiatry       Date:  1991-11

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  The two-syndrome concept: origins and current status.

Authors:  T J Crow
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

5.  Hypofrontality does not occur with 6-hydroxydopamine lesions of the medial prefrontal cortex in rat brain.

Authors:  M Kurachi; S Yasui; T Kurachi; R Shibata; M Murata; H Hagino; Y Tanii; K Kurata; M Suzuki; Y Sakurai
Journal:  Eur Neuropsychopharmacol       Date:  1995-03       Impact factor: 4.600

6.  Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy.

Authors:  V Peralta; J de Leon; M J Cuesta
Journal:  Br J Psychiatry       Date:  1992-09       Impact factor: 9.319

7.  The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics.

Authors:  B Pakkenberg
Journal:  Schizophr Res       Date:  1992-07       Impact factor: 4.939

8.  Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

Authors:  N D Volkow; A P Wolf; P Van Gelder; J D Brodie; J E Overall; R Cancro; F Gomez-Mont
Journal:  Am J Psychiatry       Date:  1987-02       Impact factor: 18.112

9.  Schizophrenia: the nature of the psychological disturbance and its possible neurochemcial basis.

Authors:  T J Crow
Journal:  Ciba Found Symp       Date:  1979

10.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

View more
  9 in total

1.  Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.

Authors:  Carol J Lane; Elton T C Ngan; Lakshmi N Yatham; Tom J Ruth; Peter F Liddle
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

Review 2.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

3.  Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change.

Authors:  E T C Ngan; C J Lane; T J Ruth; P F Liddle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 4.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

5.  Saccadic eye movements and regional cerebral blood flow in schizophrenic patients.

Authors:  M Matsui; M Kurachi; S Yuasa; M Aso; Y Tonoya; S Nohara; O Saitoh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

6.  Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.

Authors:  Ryosuke Hanaya; Estelle Koning; Arielle Ferrandon; Annie Schweitzer; Annie Andrieux; Astrid Nehlig
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

7.  Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia.

Authors:  Heather C Whalley; Viktoria-Eleni Gountouna; Jeremy Hall; Andrew McIntosh; Marie-Claire Whyte; Enrico Simonotto; Dominic E Job; David G C Owens; Eve C Johnstone; Stephen M Lawrie
Journal:  BMC Psychiatry       Date:  2007-10-29       Impact factor: 3.630

8.  Aberrant perfusion and its connectivity within default mode network of first-episode drug-naïve schizophrenia patients and their unaffected first-degree relatives.

Authors:  Long-Biao Cui; Liu-Xian Wang; Ping Tian; Hua-Ning Wang; Min Cai; Fan Guo; Chen Li; Yu-Jing Wu; Peng-Gang Qiao; Zi-Liang Xu; Lin Liu; Hong He; Wen-Jun Wu; Yi-Bin Xi; Hong Yin
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

9.  Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia.

Authors:  Lucy D Vanes; Elias Mouchlianitis; Krisna Patel; Erica Barry; Katie Wong; Megan Thomas; Timea Szentgyorgyi; Dan Joyce; Sukhwinder Shergill
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.